Breathe Technologies
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$4.0m | Series A | ||
$15.0m | Series B | ||
$23.0m | Series C | ||
$7.3m | Series D | ||
$810k | Seed | ||
N/A | $6.3m | Early VC | |
$130m Valuation: $130m | Acquisition | ||
Total Funding | $56.4m |
Recent News about Breathe Technologies
EditBreathe Technologies, now part of the Hillrom family, specializes in developing and manufacturing advanced medical technologies aimed at patients suffering from respiratory insufficiency and neuromuscular diseases. The company's flagship product, the Ventilation System, is the first truly wearable ventilator on the market, designed to provide continuous ventilation while significantly improving patient mobility. This innovative system comprises three main components: the Ventilator, the Compressor, and related accessories, all of which must be used together to ensure optimal performance and compliance with HCPCS codes E0465 and E0466.
Breathe Technologies operates within the medical device industry, primarily serving healthcare providers, hospitals, and patients who require advanced respiratory support. The business model focuses on the sale of its proprietary Ventilation System and related accessories, generating revenue through direct sales and partnerships with healthcare institutions. Additionally, the company offers guidance on coding, coverage, and reimbursement matters, ensuring that suppliers and healthcare providers can navigate the complex landscape of medical billing and insurance claims effectively.
By integrating cutting-edge technology with patient-centric design, Breathe Technologies aims to enhance the quality of life for individuals with severe respiratory conditions, enabling them to lead more active and independent lives.
Keywords: wearable ventilators, respiratory insufficiency, neuromuscular diseases, patient mobility, medical devices, healthcare providers, continuous ventilation, Hillrom family, coding guidance, reimbursement support.